LTB4 production is elevated in preclinical and clinical lymphedema

Slides:



Advertisements
Similar presentations
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Interleukin 6 and Interleukin 8 as Potential Biomarkers.
Advertisements

Volume 62, Issue 6, Pages (June 2015)
Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression. CSF1 is increased in blood of melanoma patients and correlates.
LTB4 production is elevated in preclinical and clinical lymphedema
Fig. 6. dAST directly from clinical samples using dPCR and dLAMP for quantification. dAST directly from clinical samples using dPCR and dLAMP for quantification.
Fig. 5. Blocking LTB4 during initial lymphangiogenesis period abrogates the therapeutic benefit of LTB4 antagonism. Blocking LTB4 during initial lymphangiogenesis.
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
Fig. 2. Bestatin treatment improves tail anatomy and restores lymphatic function. Bestatin treatment improves tail anatomy and restores lymphatic function.
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 1. Ketoprofen efficacy in a preclinical model of lymphedema can be attributed to its inhibition of LTB4. Ketoprofen efficacy in a preclinical model.
Fig. 3. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis and survival. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis.
Elevation of formylated N-terminal peptides in patients with acute respiratory distress syndrome (ARDS). Elevation of formylated N-terminal peptides in.
Molecular Therapy - Methods & Clinical Development
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro
Expression of CD36 and psap in a TMA of human ovarian cancer patients
FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.
Supplementary Table 1, Chauvier et al., 2011
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 1. Muscles of LAMA2 MD patients and dyW/dyW mice contain high amounts of laminin-α4 and show deficits in BM. Muscles of LAMA2 MD patients and dyW/dyW.
Dysfunctional antifungal neutrophils have impaired expression of IFN-inducible genes. Dysfunctional antifungal neutrophils have impaired expression of.
Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.
qRT-PCR analysis of expression profile of GbNAC1.
Fig. 4. Induced Zbtb7a in lungs is localized to AMs.
Fig. 7 Correlation of NHP and human ISGs.
Fig. 1. Generation of the ΔEx50 mouse model.
Fig. 3. The effect of VRC01 infusion on virus load in plasma and blood CD4 T cells during ART. The effect of VRC01 infusion on virus load in plasma and.
Fig. 1 ZIKV RNA in blood and tissues.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 6. TIV-09, but not MIV-09, induces an IFN signature in the blood of vaccinated individuals at day 1. TIV-09, but not MIV-09, induces an IFN signature.
Fig. 6. Nontaxane chemotherapies induce TMEM-dependent prometastatic changes in the breast cancer microenvironment. Nontaxane chemotherapies induce TMEM-dependent.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 3 NK cells are enriched in ICB-sensitive tumors in mouse models and patients and are required for response. NK cells are enriched in ICB-sensitive.
Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
Fig. 1. DEL-1 is expressed by human and mouse osteoclasts.
Fig. 7 BMS reduces the elevated expression of type I IFN–regulated genes both ex vivo in blood from patients with lupus and in a phase 1 study of.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models by Pauline Désogère, Luis F. Tapias, Lida P. Hariri,
Fig. 3 Proteomic analysis and Western blot analysis of protein cargos of various EVs. Proteomic analysis and Western blot analysis of protein cargos of.
Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.
Fig. 4. Paclitaxel promotes the expression of invasive isoforms of MENA in the primary breast cancer microenvironment. Paclitaxel promotes the expression.
by Dezhi Kang, Baochen Shi, Marie C. Erfe, Noah Craft, and Huiying Li
Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation.
Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.
Fig. 4 Effects of morphogen priming of engineered mesenchymal condensations on in vitro chondrogenic lineage specification at the time of implantation.
Fig. 2 Effect of CSF sTREM2– and CSF sTREM2–to–p-tau181 ratio on changes in cognition. Effect of CSF sTREM2– and CSF sTREM2–to–p-tau181 ratio on changes.
Compensatory metabolic pathways during long-term selegiline treatment
Fig. 4 ID1 is a direct CREB target.
Comparison of brain temperature values in the basal ganglia and white matter according to the initial degree of encephalopathy and the presence of brain.
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro
Fig. 4. miR promotes cardiomyocyte proliferation through regulation of Hippo pathway kinases. miR promotes cardiomyocyte proliferation through.
Fig. 1. Dysbiosis of the skin microbiome in AD is associated with S
Fig. 3 Characterization of SGN responses to optogenetic stimulation.
Effects of highly concentrated SFN provided as BSE in T2D patients
Fig. 3. miR overexpression leads to increased cell proliferation as well as altered differentiation and metabolism in cardiomyocytes. miR
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Fig. 5 Clustering of the distal gut microbiome, the C
Fig. 1 TLR2 expression is induced during OIS.
Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 1. APP/PS1;C3 KO mice show improved cognitive flexibility (reversal) compared to APP/PS1 mice at 16 months of age. APP/PS1;C3 KO mice show improved.
Fig. 1 Isopropanol tolerance variation among E. faecium isolates.
Fig. 8 Immune correlates of protection.
Fig. 3 Neuroblast-induced morphological dynamics of reactive astrocytes involve the inhibition of Cdc42-regulated actin polymerization. Neuroblast-induced.
Fig. 5. Paclitaxel promotes breast cancer cell dissemination and metastasis in a MENA-dependent manner. Paclitaxel promotes breast cancer cell dissemination.
Fig. 6 tlr2 is necessary for SASP activation in vivo.
Presentation transcript:

Fig. 4. LTB4 production is elevated in preclinical and clinical lymphedema. LTB4 production is elevated in preclinical and clinical lymphedema. (A) LTB4 concentrations in the lymph fluid, measured by liquid chromatography–tandem mass spectrometry (LC-MS/MS) over time as mouse tail lymphedema developed; n = 6. (B) Mouse serum LTB4 concentrations, measured by LC-MS/MS. Blood serum was collected on postsurgical day 24; n = 6. (C) Transcripts of Ltb4r1 and Ltb4r2 in the tail skin, measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR); n = 5. (D) Quantification of 5-LO–positive macrophages in the mouse tail skin in fig. S3B; n = 5. (E) LTB4 concentrations in the blood serum of healthy controls (n = 21) and lymphedema (n = 18) patients, measured by LC-MS/MS. Demographic data are shown in table S1. (F) Quantification of 5-LO–expressing macrophages in patient skin samples in fig. S8; n = 5. For (A), (B), and (E), data are presented in box-and-whiskers plots showing minimal to maximal values and all data points; for (C), (D), and (F), data are presented as means and SEM; comparisons with day 0 samples in (A) and (C) were made using Kruskal-Wallis test followed by Dunn’s multiple comparisons test for post hoc analyses; comparisons as indicated in (B), (D), (E), and (F) used the Mann-Whitney test. Wen Tian et al., Sci Transl Med 2017;9:eaal3920 Copyright © 2017, American Association for the Advancement of Science